Dr. Bruce Pawel oversees care delivery and quality for the Anatomic Pathology team, as well as development of outreach, recruitment and growth of the Division’s clinical, research and educational programs. He serves on the Department’s senior leadership team and mentoring committee, guiding faculty and trainees to academic success and professional development.
Dr. Pawel is an internationally renowned expert on the pathology of sarcomas, neuroblastoma and other childhood solid tumors. His research focuses on identifying potential targets for therapy of neuroblastoma, pediatric embryonal tumors and sarcomas. He has 35 years of clinical, academic and research experience.
Rutgers - New Jersey Medical School
Mt. Sinai St. Luke's-Roosevelt Hospital Center, Internal Medicine
Rutgers - New Jersey Medical School, Pathology
Nationwide Children's Hospital, Pediatric Pathology
Pathology, American Board of Pathology
Dahmoush H, Anupindi SA, Pawel BR, Chauvin NA: Multimodality imaging findings of massive ovarian edema in children. Pediatric Radiology 47(5): 576-583, Feb 2017. PMID: 28246900
Li Y, Pawel BR, Hill DA, Epstein JI, Argani P: Pediatric cystic nephroma is morphologically, immunohistochemically, and genetically distinct from adult cystic nephroma. The American Journal of Surgical Pathology 41(4): 472-481, Feb 2017. PMCID: PMC5350016
Bosse KR, Raman P, Zhu Z, Lane M, Martinez D, Heitzeneder S, Rathi KS, Kendsersky NM, Randall M, Donovan L, Morrissy S, Sussman RT, Zhelev DV, Feng Y, Wang Y, Hwang J, Lopez G, Harenza JL, Wei JS, Pawel B, Bhatti T, Santi M, Ganguly A, Khan J, Marra MA, Taylor MD, Dimitrov DS, Mackall CL, Maris JM: Identification of GPC2 as an oncoprotein and candidate immunotherapeutic target in high-risk neuroblastoma. Cancer Cell 32(3): 295-309.e12, Sep 2017. PMCID: PMC5600520
Niazi M Khalid K, Chung JH, Heaton-Johnson KJ, Martinez D, Castellanos R, Irwin MS, Master SR, Pawel BR, Gurcan MN, Weiser DA: Advancing clinicopathologic diagnosis of high-risk neuroblastoma using computerized image analysis and proteomic profiling. Pediatric and Developmental Pathology: 20(5): 394-402, Sep-Oct 2017. PMID: 28420318
Majzner RG, Simon JS, Grosso JF, Martinez D, Pawel BR, Santi M, Merchant MS, Geoerger B, Hezam I, Marty V, Vielh P, Daugaard M, Sorensen PH, Mackall CL, Maris JM: Assessment of programmed death-ligand 1 expression and tumor-associated immune cells in pediatric cancer tissues. Cancer 123(19): 3807-3815, Oct 2017. PMID: 28608950
Pathology of neuroblastoma, identification of potential protein targets for directed therapy.
Pathology of pediatric embryonal tumors and sarcomas, identification of potential protein targets for directed therapy.